Feed HSIC
HS

Henry Schein HSIC NASDAQ · Healthcare · United States

$84.96 -1.46% -$1.26

Summary

50 / 100 · Bulios Score

What speaks for it

  • It bought back its own shares for $850.0M in the last fiscal year, 9.1% of its market value.
  • It has been profitable 6 years in a row.

What to watch

  • The share price is above the Bulios Fair Price.
  • Earnings per share fell by 5.8% a year over the last 3 years.
  • Out of every 100 USD of revenue, only 3.1 USD is left as net profit.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Overvalued Price today $84.96

By our assumptions the business is worth less than its shares cost today.

P/E today 22.3 2.9% higher
5-year average P/E 21.7
P/E today 22.3
Medical - Distribution industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 22.3 USD for 1 USD of yearly profit. Over the last five years it was 21.7 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 5.4% a year over 5 years. Over the last 3 years it grew by 1.4% a year. For the next fiscal year analysts expect revenue to grow by 2.7%. Earnings per share fell by 5.8% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 USD of revenue goes

Net profit, industry median (Medical - Distribution) 1.4 USD

Out of every 100 USD of revenue, 3.1 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 7.4 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $97.14 is 14% above today's price. 50% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2018

By product

By region

Healthcare Distribution brings in 96% of revenue. Technology grew fastest, by 9.7% a year.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy